Physician profile
Junping Yang
NPI 1831120773
$45,617.40
in general payments reported to CMS, 2019-2025
53 companies · $3,192 in 2025
The $3,192 reported for 2025 was more than what 84% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $8,100 · 2021: $6,084 · 2022: $1,851 · 2023: $2,363 · 2024: $2,958 · 2025: $3,192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,556 · Honoraria: $950 · Education: $7.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,555.58 |
| Honoraria | $950.00 |
| Education | $7.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $28,389.35 | 2019-2024 | Farxiga, Lokelma |
| Aegerion Pharmaceuticals, INC. | $3,237.42 | 2019 | |
| Novo Nordisk INC | $1,393.91 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Mannkind Corporation | $1,336.55 | 2020-2024 | Afrezza |
| Abbott Laboratories | $955.33 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Chiesi USA, INC. | $950.00 | 2025 | Myalept, Mycapssa |
| Amgen INC. | $830.47 | 2019-2025 | Tepezza, Evenity, Repatha |
| Lilly USA, LLC | $824.81 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Cequr Corporation | $759.57 | 2023-2025 | Cequr Simplicity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $699.39 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Corcept Therapeutics | $674.50 | 2022-2025 | Korlym |
| Medtronic, INC. | $591.51 | 2021-2025 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Insulet Corporation | $527.33 | 2019-2024 | Omnipod |
| Bayer Healthcare Pharmaceuticals INC. | $505.63 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $491.86 | 2019-2025 |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $310.17 | 2019-2025 | Dexcom G6 Transmitter |
| Medtronic Minimed, INC. | $288.32 | 2019-2020 | |
| Tandem Diabetes Care, INC. | $259.54 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Xeris Pharmaceuticals, INC. | $250.85 | 2020-2025 | Recorlev, Gvoke Hypopen |
| Amarin Pharma, INC. | $239.46 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $205.61 | 2019-2020 | |
| Horizon Therapeutics Plc | $185.88 | 2021-2023 | Tepezza |
| Ascendis Pharma Endocrinology INC | $151.28 | 2025 | Yorvipath |
| Ascensia Diabetes Care US INC. | $144.55 | 2023-2025 | |
| Abbvie INC. | $131.19 | 2019-2025 | Synthroid |
| Ibsa Pharma INC. | $122.54 | 2019-2025 | Licart, Tirosint, Tirosint |
| Lexicon Pharmaceuticals, INC. | $116.66 | 2024 | Inpefa |
| Antares Pharma, INC. | $98.88 | 2019-2024 | Xyosted |
| Pfizer INC. | $89.73 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $81.35 | 2022-2025 | |
| Beta Bionics, INC. | $76.35 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Janssen Pharmaceuticals, INC | $69.53 | 2019-2020 | |
| Ipsen Biopharmaceuticals, INC | $57.90 | 2019 | |
| Amneal Pharmaceuticals LLC | $54.74 | 2019-2024 | Unithroid |
| Blueprint Medicines Corporation | $51.11 | 2022 | |
| Amryt Pharma Holdings Ltd | $48.71 | 2022 | |
| Verity Pharmaceuticals INC. | $46.94 | 2024-2025 | Tlando |
| Alexion Pharmaceuticals, INC. | $43.73 | 2019 | |
| Madrigal Pharmaceuticals | $40.35 | 2025 | Rezdiffra |
| Radius Health, INC. | $37.60 | 2023 | Tymlos |
| Glaxosmithkline, LLC. | $30.45 | 2025 | Shingrix, Arexvy |
| Grt US Holding, INC. | $28.22 | 2022 | |
| Embecta Corp. | $23.20 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Averitas Pharma INC. | $22.51 | 2023 | Qutenza |
| Nevro Corp. | $20.05 | 2022 | |
| Recordati_rare_diseases_inc. | $19.43 | 2025 | Isturisa |
| Shire North American Group INC | $18.19 | 2019 | |
| Sequel Med Tech, LLC | $17.69 | 2025 | Twiist |
| Kyowa Kirin, INC. | $17.32 | 2024 | Crysvita |
| Esperion Therapeutics, INC. | $16.97 | 2025 | Nexletol |
| Ultragenyx Pharmaceutical INC. | $12.61 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $12.00 | 2019 | |
| Organon LLC | $8.16 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Junping Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.